These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 9412003)

  • 21. Polyarthralgia-arthritis syndrome induced by low doses of rifabutin.
    Le Gars L; Collon T; Picard O; Kaplan G; Berenbaum F
    J Rheumatol; 1999 May; 26(5):1201-2. PubMed ID: 10332992
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Rifampin-resistant Mycobacterium kansasii infection in a patient with AIDS who was receiving rifabutin.
    Meynard JL; Lalande V; Meyohas MC; Petit JC; Frottier J
    Clin Infect Dis; 1997 Jun; 24(6):1262-3. PubMed ID: 9195097
    [No Abstract]   [Full Text] [Related]  

  • 23. Treatment outcome of tuberculosis patients diagnosed with human immunodeficiency virus infection in Iran.
    Tabarsi P; Baghaei P; Mirsaeidi M; Amiri M; Alipanah N; Emami H; Novin A; Mansouri D; Masjedi MR; Velayati AA
    Saudi Med J; 2008 Jan; 29(1):148-50. PubMed ID: 18176695
    [No Abstract]   [Full Text] [Related]  

  • 24. [Rifabutin].
    Enferm Infecc Microbiol Clin; 1996 May; 14(5):329-30. PubMed ID: 8744377
    [No Abstract]   [Full Text] [Related]  

  • 25. Use of rifabutin in the treatment of pulmonary tuberculosis.
    Grassi C; Peona V
    Clin Infect Dis; 1996 Apr; 22 Suppl 1():S50-4. PubMed ID: 8785257
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Relapse and acquired rifampin resistance in HIV-infected patients with tuberculosis treated with rifampin- or rifabutin-based regimens in New York City, 1997-2000.
    Li J; Munsiff SS; Driver CR; Sackoff J
    Clin Infect Dis; 2005 Jul; 41(1):83-91. PubMed ID: 15937767
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Treatment review. Rifabutin.
    Co M
    J Assoc Nurses AIDS Care; 1994; 5(1):45-50. PubMed ID: 8167311
    [No Abstract]   [Full Text] [Related]  

  • 28. Rifabutin versus placebo in combination with three drugs in the treatment of nontuberculous mycobacterial infection in patients with AIDS.
    Dautzenberg B; Olliaro P; Ruf B; Esposito R; Opravil M; Hoy JF; Rozenbaum W; Carosi GP; Micoud M; L'Age M; Pirotta N; Sassella D
    Clin Infect Dis; 1996 Apr; 22(4):705-8. PubMed ID: 8729209
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Discoloration of intraocular lens subsequent to rifabutin use.
    Jones DF; Irwin AE
    Arch Ophthalmol; 2002 Sep; 120(9):1211-2. PubMed ID: 12215098
    [No Abstract]   [Full Text] [Related]  

  • 30. Potential role of rifabutin in prophylaxis for tuberculosis and infections due to multiple opportunistic pathogens.
    Chaisson RE
    Clin Infect Dis; 1996 Apr; 22 Suppl 1():S61-6; discussion S66-9. PubMed ID: 8785259
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Updated guidelines for the use of rifabutin or rifampin for the treatment and prevention of tuberculosis among HIV-infected patients taking protease inhibitors or nonnucleoside reverse transcriptase inhibitors.
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 2000 Mar; 49(9):185-9. PubMed ID: 11795500
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Hold the big MAC.
    Young A
    Notes Undergr; 1996 Apr; (no 32):6. PubMed ID: 11363450
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Nontuberculous mycobacteriosis; the present status and in the future. Infection with human immunodeficiency virus (HIV) and nontuberculous mycobacteriosis].
    Mizutani S
    Kekkaku; 1998 Feb; 73(2):87-92. PubMed ID: 9545702
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Rifabutin-associated panuveitis with retinal vasculitis in pulmonary tuberculosis.
    Skolik S; Willermain F; Caspers LE
    Ocul Immunol Inflamm; 2005 Dec; 13(6):483-5. PubMed ID: 16321897
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Recurrent bilateral anterior uveitis with hypopyon and rifabutin therapy.
    Zenone T; Boibieux A; Fleury J; Chaumentin G; Daoud F; Burgat C; Peyramond D; Bertrand JL
    Scand J Infect Dis; 1996; 28(3):325-6. PubMed ID: 8863373
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Rifabutin-associated hypopyon uveitis in patient with acquired immunodeficiency syndrome].
    Ishiguchi N; Ueno K; Yanagihara M; Kadono K; Oshika T
    Nippon Ganka Gakkai Zasshi; 2010 Aug; 114(8):683-6. PubMed ID: 20803988
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Manifestations, diagnosis and treatment of non-tuberculous mycobacterial infections in patients with HIV infection].
    Payen MC; De Wit S; Clumeck N
    Rev Mal Respir; 1997 Dec; 14 Suppl 5():S142-51. PubMed ID: 9496599
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Recent development in the treatment and prevention of disseminated Mycobacterium avium complex (MAC).
    Schouten JT; Whittemore S
    STEP Perspect; 1996; 8(3):5-6. PubMed ID: 11364267
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Pharmacokinetic evaluation of rifabutin in combination with lopinavir-ritonavir in patients with HIV infection and active tuberculosis.
    Boulanger C; Hollender E; Farrell K; Stambaugh JJ; Maasen D; Ashkin D; Symes S; Espinoza LA; Rivero RO; Graham JJ; Peloquin CA
    Clin Infect Dis; 2009 Nov; 49(9):1305-11. PubMed ID: 19807276
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A regimen containing rifabutin for the treatment of tuberculosis in patients intolerant to rifampin.
    Tattevin P; Revest M; Dupont M; Arvieux C; Michelet C
    Clin Infect Dis; 2003 Jan; 36(1):127-8. PubMed ID: 12491218
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.